HIF-1 can activate the transcription of glucose transporters and glycolytic enzymes and increase glucose metabolism through the glycolytic pathway, but reduce glucose entry into the tricarboxylic acid cycle (TCA cycle) 313, and this metabolic pattern is beneficial to cancer cell proliferation. This evidence concerns the gene HIF1A and cancer.